Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer

BACKGROUND: Preclinical data suggest that oncogene (EGFR and KRAS) events regulate tumor procoagulant activity. However, few studies have prospectively investigated the clinical relevance between the presence of EGFR or KRAS mutations and occurrence of venous thromboembolism(VTE) in patients with no...

Descripción completa

Detalles Bibliográficos
Autores principales: Dou, Feifei, Li, Huiqiao, Zhu, Min, Liang, Lirong, Zhang, Yuan, Yi, Jiawen, Zhang, Yuhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944093/
https://www.ncbi.nlm.nih.gov/pubmed/29743116
http://dx.doi.org/10.1186/s12931-018-0791-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944093/
https://www.ncbi.nlm.nih.gov/pubmed/29743116
http://dx.doi.org/10.1186/s12931-018-0791-2

Ejemplares similares